Table 8.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1999 to 2008

Recipients with Kidney-Pancreas Transplants

	Transplant Year
	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008
Functioning Graft at Discharge	907	888	861	881	847	864	884	905	840	820
With Immunosuppression Info	907	886	861	881	844	851	879	891	831	815
CyA	0.0%	0.1%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
Tac	0.7%	0.9%	1.4%	2.3%	1.1%	3.4%	0.8%	1.1%	1.1%	0.6%
--- + MMF/MPA	0.0%	0.0%	0.0%	0.0%	1.1%	2.0%	1.0%	0.4%	0.0%	0.1%
CyA + MMF/MPA	0.0%	0.0%	0.0%	0.0%	0.4%	0.2%	0.7%	0.1%	0.4%	0.5%
Tac + MMF/MPA	0.6%	1.1%	0.6%	1.1%	4.0%	6.7%	14.8%	21.1%	24.2%	21.7%
Tac + OtherAntimet	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%
--- + Siro/Evero	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.2%
CyA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	1.3%	2.8%	2.8%	3.1%	2.3%	3.2%
Tac + Siro/Evero	0.0%	0.3%	1.6%	4.7%	3.6%	3.8%	6.1%	2.2%	1.2%	0.1%
--- + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.0%	2.4%	4.5%	0.2%	0.2%	0.2%	0.0%
CyA + MMF/MPA + Siro/Evero	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.3%	0.2%	0.0%	0.0%
Tac + MMF/MPA + Siro/Evero	0.0%	0.0%	1.5%	1.8%	2.1%	0.9%	1.8%	4.6%	4.5%	2.6%
--- + Steroids	2.2%	1.1%	0.1%	0.0%	1.7%	0.8%	2.2%	0.0%	0.1%	0.0%
CyA + Steroids	0.3%	0.5%	0.3%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Tac + Steroids	2.4%	1.7%	2.3%	1.8%	2.5%	1.5%	2.5%	3.0%	1.3%	2.2%
--- + MMF/MPA + Steroids	1.0%	0.1%	0.8%	0.5%	0.8%	1.3%	0.5%	0.7%	0.7%	0.9%
CyA + MMF/MPA + Steroids	19.4%	12.2%	8.5%	6.9%	5.0%	1.4%	1.8%	1.6%	1.2%	0.5%
Tac + MMF/MPA + Steroids	65.4%	64.6%	61.7%	66.2%	62.4%	64.7%	59.8%	53.6%	59.2%	64.5%
--- + OtherAntimet + Steroids	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%
CyA + OtherAntimet + Steroids	0.1%	0.3%	0.1%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%
Tac + OtherAntimet + Steroids	1.1%	1.0%	0.1%	0.5%	0.7%	0.2%	0.0%	0.6%	0.4%	0.0%
--- + Siro/Evero + Steroids	0.0%	0.0%	0.0%	0.2%	0.2%	0.4%	0.0%	0.0%	0.1%	0.1%
CyA + Siro/Evero + Steroids	0.0%	2.6%	1.6%	0.6%	1.8%	0.9%	0.9%	0.7%	0.4%	0.2%
Tac + Siro/Evero + Steroids	0.7%	6.8%	11.0%	7.3%	4.9%	2.2%	2.5%	4.4%	1.3%	1.2%
Other Regimen	6.2%	6.7%	8.1%	5.9%	4.1%	1.8%	1.0%	2.0%	1.3%	1.2%

Source: OPTN/SRTR Data as of May 4, 2009.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.